Free Trial
NASDAQ:PGEN

Precigen (PGEN) Stock Price, News & Analysis

Precigen logo
$4.55 -0.04 (-0.87%)
Closing price 04:00 PM Eastern
Extended Trading
$4.57 +0.02 (+0.44%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Precigen Stock (NASDAQ:PGEN)

Key Stats

Today's Range
$4.49
$4.82
50-Day Range
$1.42
$4.59
52-Week Range
$0.65
$4.82
Volume
10.26 million shs
Average Volume
16.49 million shs
Market Capitalization
$1.36 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.25
Consensus Rating
Moderate Buy

Company Overview

Precigen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

PGEN MarketRank™: 

Precigen scored higher than 77% of companies evaluated by MarketBeat, and ranked 240th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Precigen has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Precigen has only been the subject of 4 research reports in the past 90 days.

  • Read more about Precigen's stock forecast and price target.
  • Earnings Growth

    Earnings for Precigen are expected to grow in the coming year, from ($0.32) to ($0.20) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Precigen is -10.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Precigen is -10.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Precigen's valuation and earnings.
  • Percentage of Shares Shorted

    19.71% of the float of Precigen has been sold short.
  • Short Interest Ratio / Days to Cover

    Precigen has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Precigen has recently increased by 1.41%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Precigen does not currently pay a dividend.

  • Dividend Growth

    Precigen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    19.71% of the float of Precigen has been sold short.
  • Short Interest Ratio / Days to Cover

    Precigen has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Precigen has recently increased by 1.41%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Precigen has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Precigen this week, compared to 3 articles on an average week.
  • Search Interest

    39 people have searched for PGEN on MarketBeat in the last 30 days. This is an increase of 225% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Precigen to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Precigen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    47.10% of the stock of Precigen is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 33.51% of the stock of Precigen is held by institutions.

  • Read more about Precigen's insider trading history.
Receive PGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precigen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PGEN Stock News Headlines

Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
H.C. Wainwright Remains Bullish on Precigen (PGEN)
Analysts Set Precigen, Inc. (NASDAQ:PGEN) Target Price at $8.25
Precigen Target of Unusually High Options Trading (NASDAQ:PGEN)
See More Headlines

PGEN Stock Analysis - Frequently Asked Questions

Precigen's stock was trading at $1.12 at the start of the year. Since then, PGEN shares have increased by 306.3% and is now trading at $4.55.

Precigen, Inc. (NASDAQ:PGEN) released its quarterly earnings data on Tuesday, August, 12th. The biotechnology company reported ($0.11) earnings per share for the quarter, topping analysts' consensus estimates of ($0.14) by $0.03. The biotechnology company earned $0.86 million during the quarter, compared to analysts' expectations of $0.67 million. Precigen had a negative net margin of 2,868.66% and a negative trailing twelve-month return on equity of 842.83%.

Top institutional shareholders of Precigen include Patient Capital Management LLC (5.51%), Geode Capital Management LLC (1.27%), Bank of America Corp DE (0.28%) and JPMorgan Chase & Co. (0.26%). Insiders that own company stock include Helen Sabzevari, Randal J Kirk, Steven Frank, Jeffrey Thomas Perez, Donald P Lehr, Dean J Mitchell, Harry Jr Thomasian and Rutul R Shah.
View institutional ownership trends
.

Shares of PGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Precigen investors own include Nordic American Tankers (NAT), ZIOPHARM Oncology (ZIOP), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Hess (HES) and Boeing (BA).

Company Calendar

Last Earnings
8/12/2025
Today
8/28/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PGEN
CIK
1356090
Fax
N/A
Employees
190
Year Founded
N/A

Price Target and Rating

High Price Target
$8.50
Low Price Target
$8.00
Potential Upside/Downside
+81.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.42)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$126.24 million
Net Margins
-2,868.66%
Pretax Margin
-2,870.32%
Return on Equity
-842.83%
Return on Assets
-78.98%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.71
Quick Ratio
2.71

Sales & Book Value

Annual Sales
$3.92 million
Price / Sales
346.24
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.12) per share
Price / Book
-37.96

Miscellaneous

Outstanding Shares
297,970,000
Free Float
157,628,000
Market Cap
$1.36 billion
Optionable
Optionable
Beta
1.87

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:PGEN) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners